- STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputerBristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.STAT · 4d ago↗ source
- Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trialA phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study scheduled to report data in October, the biotech is holding off on…Fierce Biotech · 4d ago↗ source
- Tempus buys out cancer genomics partner Personalis in $1.5 billion dealTempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed up in oncology.